Oxford University and Moderna launch trials of vaccine that could prevent cancer

The jab targets patients with Lynch syndrome, who are at high risk of bowel and ovarian cancer

The jab targets patients with Lynch syndrome, who are at high risk of bowel and ovarian cancer

The jab targets patients with Lynch syndrome, who are at high risk of bowel and ovarian cancer